Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Date of authorisation: 23/02/2001, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Date of authorisation: 23/02/2001, Revision: 23, Status: Authorised

Quarterly System Demo Q1 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2024, 09:00 (CET) to 26 March 2024, 13:30 (CET)

Quarterly System Demo Q1 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2024, 09:00 (CET) to 26 March 2024, 13:30 (CET)

Checklist for the submission of Type IA and Type IB (without linguistic review) product information annexes and Annex A (if applicable) - human

Checklist for the submission of Type IA and Type IB (without linguistic review) product information annexes and Annex A (if applicable) - human

Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 36, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness